Villons-les-Buissons, France

Lea Louvel

This inventor holds 2 USPTO granted patents. Top assignee: Viramal Limited. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lea Louvel. Retrieved from https://idiyas.com/inventor/lea-louvel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lea Louvel: Innovator in Pharmaceutical Gel Composition

Introduction

Lea Louvel is a prominent inventor based in Villons-les-Buissons, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of mucoadhesive gel compositions. Her innovative work focuses on delivering therapeutic agents effectively while avoiding hepatic first-pass metabolism.

Latest Patents

Lea Louvel holds a patent for a pharmaceutical mucoadhesive gel composition. This gel is designed for the delivery of therapeutic agents, such as progesterone, through buccal, nasal, vaginal, and rectal administration. The composition includes a vehicle with a gel-forming agent and a bioadhesive agent, ensuring that the therapeutic agent is effectively dispersed or suspended within the vehicle.

Career Highlights

Lea Louvel is associated with Viramal Limited, where she continues to advance her research and development efforts. Her work has garnered attention for its potential to improve the efficacy of drug delivery systems.

Collaborations

Lea collaborates with notable colleagues, including William Bologna and François Boutignon. Their combined expertise contributes to the innovative projects at Viramal Limited.

Conclusion

Lea Louvel's contributions to pharmaceutical innovations, particularly in mucoadhesive gel compositions, highlight her role as a leading inventor in the field. Her work promises to enhance therapeutic delivery methods and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…